These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 9431831

  • 1. Characterization of the cytochrome P450 isoenzymes involved in the in vitro N-dealkylation of haloperidol.
    Pan LP, Wijnant P, De Vriendt C, Rosseel MT, Belpaire FM.
    Br J Clin Pharmacol; 1997 Dec; 44(6):557-64. PubMed ID: 9431831
    [Abstract] [Full Text] [Related]

  • 2. In-vitro characterization of the cytochrome P450 isoenzymes involved in the back oxidation and N-dealkylation of reduced haloperidol.
    Pan LP, De Vriendt C, Belpaire FM.
    Pharmacogenetics; 1998 Oct; 8(5):383-9. PubMed ID: 9825830
    [Abstract] [Full Text] [Related]

  • 3. In vitro characterization of the metabolism of haloperidol using recombinant cytochrome p450 enzymes and human liver microsomes.
    Fang J, McKay G, Song J, Remillrd A, Li X, Midha K.
    Drug Metab Dispos; 2001 Dec; 29(12):1638-43. PubMed ID: 11717183
    [Abstract] [Full Text] [Related]

  • 4. Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamily.
    Gorski JC, Jones DR, Wrighton SA, Hall SD.
    Biochem Pharmacol; 1994 Jul 05; 48(1):173-82. PubMed ID: 8043020
    [Abstract] [Full Text] [Related]

  • 5. In vitro study on the involvement of CYP1A2, CYP2D6 and CYP3A4 in the metabolism of haloperidol and reduced haloperidol.
    Pan L, Belpaire FM.
    Eur J Clin Pharmacol; 1999 Oct 05; 55(8):599-604. PubMed ID: 10541779
    [Abstract] [Full Text] [Related]

  • 6. Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms.
    Renwick AB, Surry D, Price RJ, Lake BG, Evans DC.
    Xenobiotica; 2000 Oct 05; 30(10):955-69. PubMed ID: 11315104
    [Abstract] [Full Text] [Related]

  • 7. Identification of the human cytochrome P450 isoforms mediating in vitro N-dealkylation of perphenazine.
    Olesen OV, Linnet K.
    Br J Clin Pharmacol; 2000 Dec 05; 50(6):563-71. PubMed ID: 11136295
    [Abstract] [Full Text] [Related]

  • 8. In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9).
    Wen X, Wang JS, Kivistö KT, Neuvonen PJ, Backman JT.
    Br J Clin Pharmacol; 2001 Nov 05; 52(5):547-53. PubMed ID: 11736863
    [Abstract] [Full Text] [Related]

  • 9. Metabolism of Zaleplon by human hepatic microsomal cytochrome P450 isoforms.
    Renwick AB, Mistry H, Ball SE, Walters DG, Kao J, Lake BG.
    Xenobiotica; 1998 Apr 05; 28(4):337-48. PubMed ID: 9604298
    [Abstract] [Full Text] [Related]

  • 10. Cytochrome P-450 enzymes and FMO3 contribute to the disposition of the antipsychotic drug perazine in vitro.
    Störmer E, Brockmöller J, Roots I, Schmider J.
    Psychopharmacology (Berl); 2000 Sep 05; 151(4):312-20. PubMed ID: 11026737
    [Abstract] [Full Text] [Related]

  • 11. [O-methyl 14C]naproxen O-demethylase activity in human liver microsomes: evidence for the involvement of cytochrome P4501A2 and P4502C9/10.
    Rodrigues AD, Kukulka MJ, Roberts EM, Ouellet D, Rodgers TR.
    Drug Metab Dispos; 1996 Jan 05; 24(1):126-36. PubMed ID: 8825200
    [Abstract] [Full Text] [Related]

  • 12. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
    Eagling VA, Tjia JF, Back DJ.
    Br J Clin Pharmacol; 1998 Feb 05; 45(2):107-14. PubMed ID: 9491822
    [Abstract] [Full Text] [Related]

  • 13. Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes.
    Bourrié M, Meunier V, Berger Y, Fabre G.
    J Pharmacol Exp Ther; 1996 Apr 05; 277(1):321-32. PubMed ID: 8613937
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
    Zhao XJ, Yokoyama H, Chiba K, Wanwimolruk S, Ishizaki T.
    J Pharmacol Exp Ther; 1996 Dec 05; 279(3):1327-34. PubMed ID: 8968357
    [Abstract] [Full Text] [Related]

  • 16. Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions.
    Prakash C, Kamel A, Cui D, Whalen RD, Miceli JJ, Tweedie D.
    Br J Clin Pharmacol; 2000 Dec 05; 49 Suppl 1(Suppl 1):35S-42S. PubMed ID: 10771452
    [Abstract] [Full Text] [Related]

  • 17. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes.
    Wen X, Wang JS, Neuvonen PJ, Backman JT.
    Eur J Clin Pharmacol; 2002 Jan 05; 57(11):799-804. PubMed ID: 11868802
    [Abstract] [Full Text] [Related]

  • 18. Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites.
    Botsch S, Gautier JC, Beaune P, Eichelbaum M, Kroemer HK.
    Mol Pharmacol; 1993 Jan 05; 43(1):120-6. PubMed ID: 8423765
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Multiple human cytochromes contribute to biotransformation of dextromethorphan in-vitro: role of CYP2C9, CYP2C19, CYP2D6, and CYP3A.
    von Moltke LL, Greenblatt DJ, Grassi JM, Granda BW, Venkatakrishnan K, Schmider J, Harmatz JS, Shader RI.
    J Pharm Pharmacol; 1998 Sep 05; 50(9):997-1004. PubMed ID: 9811160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.